14-23389062-AGGG-AGG

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_002471.4(MYH6):​c.3979-8delC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.35 ( 8254 hom., cov: 0)
Exomes 𝑓: 0.31 ( 26611 hom. )
Failed GnomAD Quality Control

Consequence

MYH6
NM_002471.4 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:9O:2

Conservation

PhyloP100: 0.275

Publications

5 publications found
Variant links:
Genes affected
MYH6 (HGNC:7576): (myosin heavy chain 6) Cardiac muscle myosin is a hexamer consisting of two heavy chain subunits, two light chain subunits, and two regulatory subunits. This gene encodes the alpha heavy chain subunit of cardiac myosin. The gene is located approximately 4kb downstream of the gene encoding the beta heavy chain subunit of cardiac myosin. Mutations in this gene cause familial hypertrophic cardiomyopathy and atrial septal defect 3. [provided by RefSeq, Feb 2017]
MYH6 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 14
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
  • Keppen-Lubinsky syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial septal defect 3
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 14-23389062-AG-A is Benign according to our data. Variant chr14-23389062-AG-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 36628.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.605 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH6NM_002471.4 linkc.3979-8delC splice_region_variant, intron_variant Intron 28 of 38 ENST00000405093.9 NP_002462.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH6ENST00000405093.9 linkc.3979-8delC splice_region_variant, intron_variant Intron 28 of 38 5 NM_002471.4 ENSP00000386041.3

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
40782
AN:
115534
Hom.:
8236
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.612
Gnomad AMI
AF:
0.318
Gnomad AMR
AF:
0.236
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.157
Gnomad SAS
AF:
0.317
Gnomad FIN
AF:
0.179
Gnomad MID
AF:
0.260
Gnomad NFE
AF:
0.217
Gnomad OTH
AF:
0.338
GnomAD2 exomes
AF:
0.320
AC:
44689
AN:
139674
AF XY:
0.320
show subpopulations
Gnomad AFR exome
AF:
0.610
Gnomad AMR exome
AF:
0.262
Gnomad ASJ exome
AF:
0.283
Gnomad EAS exome
AF:
0.271
Gnomad FIN exome
AF:
0.283
Gnomad NFE exome
AF:
0.274
Gnomad OTH exome
AF:
0.288
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.308
AC:
297903
AN:
966060
Hom.:
26611
Cov.:
0
AF XY:
0.307
AC XY:
147489
AN XY:
479754
show subpopulations
African (AFR)
AF:
0.616
AC:
18501
AN:
30024
American (AMR)
AF:
0.250
AC:
6265
AN:
25092
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
4699
AN:
17628
East Asian (EAS)
AF:
0.260
AC:
5114
AN:
19658
South Asian (SAS)
AF:
0.350
AC:
21151
AN:
60378
European-Finnish (FIN)
AF:
0.254
AC:
7748
AN:
30466
Middle Eastern (MID)
AF:
0.314
AC:
1225
AN:
3902
European-Non Finnish (NFE)
AF:
0.298
AC:
219961
AN:
737912
Other (OTH)
AF:
0.323
AC:
13239
AN:
41000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6230
12460
18691
24921
31151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8586
17172
25758
34344
42930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
40854
AN:
115646
Hom.:
8254
Cov.:
0
AF XY:
0.345
AC XY:
19621
AN XY:
56834
show subpopulations
African (AFR)
AF:
0.612
AC:
23773
AN:
38846
American (AMR)
AF:
0.236
AC:
2658
AN:
11280
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
609
AN:
2598
East Asian (EAS)
AF:
0.157
AC:
477
AN:
3032
South Asian (SAS)
AF:
0.317
AC:
1085
AN:
3426
European-Finnish (FIN)
AF:
0.179
AC:
1265
AN:
7078
Middle Eastern (MID)
AF:
0.264
AC:
64
AN:
242
European-Non Finnish (NFE)
AF:
0.217
AC:
10173
AN:
46880
Other (OTH)
AF:
0.337
AC:
535
AN:
1588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.538
Heterozygous variant carriers
0
1127
2254
3380
4507
5634
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:9Other:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:5Other:1
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

May 09, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:not provided
Review Status:no classification provided
Collection Method:clinical testing

Aug 08, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Cardiomyopathy Benign:2
Apr 04, 2016
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

Dilated Cardiomyopathy, Dominant Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Atrial septal defect Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hypertrophic cardiomyopathy Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hypertrophic cardiomyopathy 14 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiovascular phenotype Benign:1
Sep 30, 2015
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Hypertrophic cardiomyopathy 2 Other:1
Institute of Human Genetics, University of Wuerzburg
Significance:not provided
Review Status:no classification provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193922652; hg19: chr14-23858271; COSMIC: COSV62452355; COSMIC: COSV62452355; API